European Autism Interventions – A Multicentre Study for Developing New Medications

European Autism Interventions – A Multicentre Study for Developing New Medications (EU-AIMS) – is the largest single grant for autism in the world, and the largest for the study of any mental health disorder in Europe.

EU-AIMS involves a novel collaboration between organisations representing affected individuals and their families (Autism Speaks), academia and Industry who for the first time in the world have come together to develop the infrastructure underpinning new treatments for autism. Patient organizations, academic and industry join forces to develop and assess novel treatment approaches for autism.

Eva Loth, Kings College London, discusses EU-AIMS

Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Concrete and Culture: A Material History

Next Article

Identification and validation of biomarkers for autism spectrum disorders

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×